Russell H Swerdlow is an expert in Neurology at University of Kansas Medical Center (United States). As of October 2026, ScienceLeadR ranks Russell H Swerdlow in the top 1% of experts worldwide for Alzheimer Disease, Dementia and Neurocognitive Disorders. Russell H Swerdlow has authored 617 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 2,674 (community average: 125). How the SLR is computed.

LeadR Profile

Russell H Swerdlow University of Kansas Medical Center United States
2 674 ScienceLeadR Reputation 2674
Network Map

Neurology

Subspecialties: Biochemistry - Genetics - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Kansas City University of Medicine and Biosciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 617

Citations

Citations: 51 007 1st author: 33 Last author: 95 Unique author: 33


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.
PMID 42671246 — dementia, alzheimer disease, machine learning, proteomics, tissues, apolipoproteins e, plasma
Alzheimers Dement20261
Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.
PMID 42395446 — alzheimer disease, pharmaceutical preparations, biomarkers, organoids, proteome, plasma
bioRxiv20260
Why diabetes matters in dementia studies: Excluding diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease.
PMID 42327071 — diabetes mellitus, hippocampus, dementia, alzheimer disease, brain, masks, amygdala, cerebellum, dna, mitochondrial, dna
bioRxiv20260
Interconnected influences of diet, gut microbiome, and metabolome on cognition across three metabolomics platforms.
PMID 42326513 — multiple chronic conditions, diet, metabolomics, diet, healthy, gastrointestinal microbiome, cognition
Res Sq20260
Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias.
PMID 42237039 — dementia, alzheimer disease, pathology, genome-wide association study, genome
Nat Genet20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 4
Phase 1 2
Phase 1/Phase 2 1

By status:

Completed 7

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 50

LeadR Networks

Main global connection map